Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are safety committees really safe?

D Bergqvist1, C D Forbes, C E Minder

  • 1Department of Surgery, University Hospital, Uppsala, Sweden.

Scottish Medical Journal
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colossal barocaloric effects near room temperature in plastic crystals of neopentylglycol.

Nature communications·2019
Same author

Health Promotion and Preventive Care Intervention for Older Community-Dwelling People: Long-Term Effects of a Randomised Controlled Trial (RCT) within the LUCAS Cohort.

The journal of nutrition, health & aging·2017
Same author

[Acceptance of preventive home visits among frail elderly persons : Participants an non-participants in a Follow-up after 2 and 4 years within the LUCAS longitudinal study].

Zeitschrift fur Gerontologie und Geriatrie·2016
Same author

Giant barocaloric effects at low pressure in ferrielectric ammonium sulphate.

Nature communications·2015
Same author

The post-hospital discharge venous thrombosis risk of the orthopedic patient.

Orthopedics·2014
Same author

[Resources and risks in old age: the LUCAS-I marker set for a classification of elderly people as fit, pre-frail and frail. First results on validity from the Longitudinal Urban Cohort Ageing Study (LUCAS), Hamburg].

Zeitschrift fur Gerontologie und Geriatrie·2012
Same journal

Association of inflammation with sex hormones and vitamin D in women: Findings from NHANES (2021-2023).

Scottish medical journal·2026
Same journal

The future of large language models in clinical and academic medicine.

Scottish medical journal·2026
Same journal

ICDMS: Integrating multimodal data for intelligent clinical decision-making in healthcare: Current trends and future directions.

Scottish medical journal·2026
Same journal

Evaluation of large language models with clinical guidance for vetting outpatient magnetic resonance imaging lumbar spine referrals.

Scottish medical journal·2026
Same journal

Improving access and reducing patient travel burden through telehealth: A quality improvement report from NHS Scotland.

Scottish medical journal·2026
Same journal

Scottish Cardiac Society 34th Annual General Meeting Thursday 2 & Friday 3 October 2025.

Scottish medical journal·2026
See all related articles

Independent safety committees are increasingly involved in clinical trials, but their roles are evolving. This paper discusses their tasks based on experiences with antithrombotic prophylaxis studies, aiming to inform broader discussions on trial safety oversight.

Area of Science:

  • Clinical Trials
  • Pharmacology
  • Medical Safety

Background:

  • Major clinical trials increasingly utilize independent safety committees or monitors.
  • The precise roles and functions of these safety bodies are not yet standardized and are continuously evolving.
  • This evolution necessitates a clear understanding of their responsibilities in ensuring trial integrity.

Purpose of the Study:

  • To discuss the defined roles and tasks of safety committees in clinical research.
  • To share collective experiences from serving on safety committees for antithrombotic prophylaxis trials.
  • To contribute to a broader debate on the function of safety committees in medical studies.

Main Methods:

  • Review of collective experiences from membership on three distinct safety committees.

Related Experiment Videos

  • Focus on studies evaluating antithrombotic prophylaxis for the prevention of deep vein thrombosis.
  • Analysis of generalizable experiences beyond specific pharmacological interventions.

    • Main Results:

    • Safety committees play a crucial, albeit evolving, role in clinical trial oversight.
    • Experiences gained from antithrombotic prophylaxis trials offer transferable insights.
    • The specific drug or intervention appears less critical than the committee's operational experience.

    Conclusions:

    • The collective experience highlights the importance of safety committees in clinical trials.
    • Generalizable lessons learned can inform the standardization of safety committee functions.
    • Further discussion is needed to establish clear guidelines for safety committee roles across diverse studies.